Beilstein Journal of Organic Chemistry · 2015 · 20 citations · 45 references
PharmacyMedicinal ChemistryOncologyCancer PharmacologyDrug DiscoverySynthetic Medicinal ChemistryNatural Product-based Drug DesignNucleobase ChemistryBiological Evaluation ReportCross CouplingNucleoside Analog SynthesisNucleoside AnalogsPurine AnalogsPurine AnaloguesPurine ChemistryStille Coupling
A unified synthetic strategy accessing novel 3'-fluorinated purine nucleoside derivatives and their biological evaluation were achieved. Novel 3'-fluorinated analogues were constructed from a common 3'-deoxy-3'-fluororibofuranose intermediate. Employing Suzuki and Stille cross-coupling reactions, fifteen 3'-fluororibose purine nucleosides 1-15 and eight 3'-fluororibose 2-chloro/2-aminopurine nucleosides 16-23 with various substituents at position 6 of the purine ring were efficiently synthesized. Furthermore, 3'-fluorine analogs of natural products nebularine and 6-methylpurine riboside were constructed via our convergent synthetic strategy. Synthesized nucleosides were tested against HT116 (colon cancer) and 143B (osteosarcoma cancer) tumor cell lines. We have demonstrated 3'-fluorine purine nucleoside analogues display potent tumor cell growth inhibition activity at sub- or low micromolar concentration.
45
Fludarabine: a new agent with major activity against chronic lymphocytic leukemia
MJ Keating, H. Kantarjian, Moshe Talpaz et al. · Blood · 1989 · 456 citations · Full text
Medicine, Oncology, Pharmacology +9